[Other] A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma

biaz Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-21 21:42
Reward20points

journal:Blood

Authors:Catherine S. Diefenbach; Opeyemi Jegede; Victoria Wang; Stephen M. Ansell; Lale Kostakoglu; Christian Steidl; Yasodha Natkunam; David W. Scott; Richard F. Ambinder; Kevin A. David; Ranjana H. Advani; Nancy L. Bartlett; Michael A. Roberston; Sachdev P. Thomas; Jonathon Cohen; Sami Ibrahimi; Gaurav Goyal; Neha Mehta-Shah; Jennifer E. Amengual; Christopher J. Forlenza; Peter D. Cole; Fenghai Duan; Kara Kelly; Brad S. Kahl

Published date:2026-4-30

DOI:10.1182/blood.2025029546

PDF link:https://ashpublications.org/bloo ... 025-029546-main.pdf

Article link:https://doi.org/10.1182/blood.2025029546

Article Source:American Society of Hematology


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list